Opportunity Information: Apply for CDC RFA GH13 1327
Apply for CDC RFA GH13 1327
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Support Services from the World Health Organization (WHO) for the Presidents Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on Mar 15, 2013 and posted on Jan 15, 2013.
- Applicants must submit their applications by May 10, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $80,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $15,000,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- The WHO has the most extensive and established presence in the regions of the world that are most heavily impacted by the HIV/AIDS pandemic. No other organization has such an entrenched international presence devoted to a comprehensive and sustainable response to HIV/AIDS. The current technical requirements for HIV/AIDS work in low resource settings are built upon the guidance documents and tools that were originally developed by WHO, which are recognized as international best practices. As a global health organization comprised of member states, WHO is in a unique position to foster country to country cooperation by utilizing existing resources from WHO designated collaborating centers in developed countries within the same region. This fostering of regional partnerships will create sustainable relationships and agreements, resulting in added synergy between neighboring countries working toward the same goal of combatting HIV/AIDS. The WHO is uniquely positioned to provide technical assistance to PEPFAR supported countries, as member states have signed on to WHO Millennium Development Goals (MDGs) to combat HIV/AIDS, malaria and other diseases. The WHO is working with countries to prevent people from becoming newly infected with HIV helping to change behaviors to reduce HIV risks increasing access to prevention commodities supporting programs for prevention of mother to child transmission of HIV promoting safe blood supplies and prevention of HIV transmission in health care settings assessing new prevention technologies to expand the availability of treatment to provide the best care for people living with HIV/ AIDS and their families to expand access and uptake of HIV testing and counseling so that people can learn their HIV status to strengthen health care systems so that they can deliver quality and sustainable HIV/AIDS programs and services and to improve HIV/AIDS information systems, including HIV surveillance, monitoring and evaluation and operational research. Due to the vast array of technical expertise, tools, experience and resources at their disposal, WHO is the most effective mechanism for providing technical support to combat the spread of HIV/AIDS, given the nature of the relationship with member states. This will be done via HIV/AIDS Interventions, guideline revisions, and capacity building in the regions, with a focus on both immediate and long term goals. These characteristics make the World Health Organization the only eligible partner to accomplish the objectives under this award.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity (CDC RFA GH13-1327) is a discretionary cooperative agreement issued by the Centers for Disease Control and Prevention (CDC) under CFDA 93.067 (Global AIDS). It is titled "Support Services from the World Health Organization (WHO) for the Presidents Emergency Plan for AIDS Relief (PEPFAR)" and was posted on January 15, 2013, with an original closing date of April 1, 2013 that was later extended to May 10, 2013. The CDC anticipated making a single award under this announcement, with an estimated total funding level of up to $80,000,000 and an award ceiling of $15,000,000 (no award floor listed). There is no cost sharing or matching requirement.
The core purpose of the award is to fund technical assistance delivered through the World Health Organization (WHO) in support of PEPFAR, including close collaboration with country and regional HIV programs in PEPFAR-supported countries as well as support to U.S. Federal partners. The work is framed to align with internationally agreed objectives set through UNAIDS, reflecting the coordinated approach established by the ten United Nations agencies that co-sponsor the Joint United Nations Programme on HIV/AIDS. In practical terms, the award is meant to strengthen HIV program quality and consistency across multiple settings by leveraging WHO norms, standards, tools, and convening power to help countries implement evidence-based HIV prevention, treatment, and health-system improvements.
Eligibility is intentionally limited. The announcement indicates that WHO is the only eligible applicant because of its unique mandate, embedded global and regional presence, and long-standing technical leadership in HIV/AIDS guidance for low-resource settings. The CDC justification emphasizes that many of the technical requirements used in HIV/AIDS programs globally are built on WHO-developed guidelines and tools that are widely recognized as international best practices. WHO is also described as uniquely positioned to foster sustainable regional partnerships and country-to-country collaboration, including through WHO-designated collaborating centers, which can help neighboring countries align strategies, share expertise, and create longer-term agreements that continue beyond the life of a single grant. This eligibility limitation is further supported by the fact that WHO member states have committed to global development targets (including Millennium Development Goals at the time) related to combating HIV/AIDS, malaria, and other diseases, giving WHO a formal platform to coordinate action with governments.
The technical scope highlighted in the opportunity spans the full continuum of HIV response. On prevention, WHO-supported activities include reducing new infections by promoting behavioral interventions that lower risk, expanding access to prevention commodities, strengthening programs to prevent mother-to-child transmission of HIV, promoting safe blood supplies, reducing HIV transmission in health care settings through improved infection prevention and control, and assessing or supporting the introduction of new prevention technologies. On treatment and care, the FOA stresses expanding availability of antiretroviral treatment and ensuring quality clinical management and support for people living with HIV and their families. A major emphasis is placed on scaling up HIV testing and counseling so more people can learn their HIV status, which is foundational for both prevention and timely treatment initiation.
Beyond direct HIV service delivery, the opportunity underscores systems strengthening as a central objective. WHO technical assistance is expected to help countries build stronger health care systems capable of delivering high-quality and sustainable HIV/AIDS programs, rather than relying on short-term, fragmented interventions. This includes improving HIV/AIDS information systems, such as surveillance, monitoring and evaluation, and operational research, which are necessary for tracking program performance, identifying gaps, improving targeting, and supporting continuous quality improvement. The announcement also references guideline revisions, HIV/AIDS interventions, and capacity building as key mechanisms, indicating that WHO would not only disseminate best practices but also update technical norms as evidence evolves and ensure local workforce and institutional capacity can implement those standards effectively over time.
Because this is a cooperative agreement, the structure implies substantial federal involvement and collaboration rather than a hands-off grant. While the announcement text provided does not lay out detailed project deliverables, the cooperative agreement model typically supports ongoing coordination with CDC and other U.S. government partners, alignment with PEPFAR strategies, and shared oversight of technical priorities and implementation. In short, the award is designed to use WHO as the primary vehicle for high-level technical leadership, harmonized guidance, and capacity-building support that helps PEPFAR-supported countries improve HIV prevention, treatment, care, and data systems in line with UNAIDS-supported global objectives.
For administrative or access issues related to the full announcement, the listed contact is the CDC Procurement and Grants Office Technical Information Management unit at (770) 488-2700 or pgotim@cdc.gov.
Frequently Asked Questions (FAQs)
1) What is the funding opportunity number and title?
The opportunity is CDC RFA GH13-1327, titled "Support Services from the World Health Organization (WHO) for the Presidents Emergency Plan for AIDS Relief (PEPFAR)."
2) Which federal agency is issuing this opportunity?
The issuing agency is the Centers for Disease Control and Prevention (CDC).
3) What type of funding mechanism is this?
This is a discretionary cooperative agreement.
4) What CFDA program is associated with this award?
The opportunity is issued under CFDA 93.067 (Global AIDS).
5) When was the opportunity posted?
It was posted on January 15, 2013.
6) What was the original closing date, and was it extended?
The original closing date was April 1, 2013, and it was later extended to May 10, 2013.
7) How many awards did CDC anticipate making under this announcement?
CDC anticipated making a single award.
8) What is the estimated total funding level for this opportunity?
The estimated total funding level is up to $80,000,000.
9) What is the award ceiling?
The award ceiling is $15,000,000.
10) Is there an award floor (minimum award amount) listed?
No award floor is listed in the information provided.
11) Is cost sharing or matching required?
No. There is no cost sharing or matching requirement.
12) What is the core purpose of this cooperative agreement?
The purpose is to fund technical assistance delivered through the World Health Organization (WHO) in support of PEPFAR, including close collaboration with country and regional HIV programs in PEPFAR-supported countries and support to U.S. Federal partners.
13) Who is eligible to apply?
Eligibility is limited to the World Health Organization (WHO), which is described as the only eligible applicant.
14) Why is eligibility limited to WHO?
The announcement justifies this limitation based on WHO's unique mandate, embedded global and regional presence, and long-standing technical leadership in HIV/AIDS guidance for low-resource settings. It also cites the widespread use of WHO-developed guidelines and tools as international best practices and WHO's ability to foster sustainable regional partnerships and country-to-country collaboration through mechanisms such as WHO-designated collaborating centers.
15) How does this opportunity relate to PEPFAR?
The cooperative agreement is intended to support PEPFAR by using WHO as a primary vehicle for high-level technical assistance, harmonized guidance, and capacity-building support to strengthen HIV prevention, treatment, care, and related systems in PEPFAR-supported countries.
16) How does this work align with UNAIDS and broader global objectives?
The work is framed to align with internationally agreed objectives set through UNAIDS and reflects a coordinated approach established by the ten United Nations agencies that co-sponsor the Joint United Nations Programme on HIV/AIDS.
17) What kinds of HIV prevention activities are included in the technical scope?
The prevention scope includes reducing new infections through behavioral interventions that lower risk, expanding access to prevention commodities, strengthening prevention of mother-to-child transmission (PMTCT) programs, promoting safe blood supplies, reducing HIV transmission in health care settings through improved infection prevention and control, and assessing or supporting the introduction of new prevention technologies.
18) What treatment and care activities are emphasized?
The opportunity stresses expanding availability of antiretroviral treatment and ensuring quality clinical management and support for people living with HIV and their families.
19) Is HIV testing and counseling part of the focus?
Yes. A major emphasis is placed on scaling up HIV testing and counseling so more people can learn their HIV status, supporting both prevention and timely treatment initiation.
20) What does the opportunity say about health systems strengthening?
Systems strengthening is presented as a central objective. WHO technical assistance is expected to help countries build stronger health care systems capable of delivering high-quality and sustainable HIV/AIDS programs, rather than relying on short-term, fragmented interventions.
21) What types of information systems and data activities are referenced?
The announcement references strengthening HIV/AIDS information systems, including surveillance, monitoring and evaluation, and operational research, to track program performance, identify gaps, improve targeting, and support continuous quality improvement.
22) Does the opportunity include guideline work and capacity building?
Yes. It references guideline revisions, HIV/AIDS interventions, and capacity building as key mechanisms, indicating that WHO would disseminate best practices, update technical norms as evidence evolves, and help ensure local capacity to implement standards over time.
23) What does it mean that this is a cooperative agreement?
As a cooperative agreement, the structure implies substantial federal involvement and collaboration rather than a hands-off grant. The information provided indicates ongoing coordination with CDC and other U.S. government partners, alignment with PEPFAR strategies, and shared oversight of technical priorities and implementation.
24) Does the provided text list detailed project deliverables?
No. The information provided notes that the announcement text does not lay out detailed project deliverables.
25) Who should be contacted for administrative or access issues related to the full announcement?
The listed contact is the CDC Procurement and Grants Office Technical Information Management unit at (770) 488-2700 or pgotim@cdc.gov.
Browse more opportunities from the same category: Health
Next opportunity: Indian Community Development Block Grant (ICDBG) Program
Previous opportunity: Personnel Development to Improve Services and Results for Children with Disabilities Preparation of Special Education, Early Intervention, and Related services Leadership Personnel CFDA Number 84.325D
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH13 1327
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH13 1327) also looked into and applied for these:
| Funding Opportunity |
|---|
| Autoimmunity Centers of Excellence, Basic Research Program (U19) Apply for RFA AI 12 060 Funding Number: RFA AI 12 060 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Autoimmunity Centers of Excellence, Clinical Research Program (UM1) Apply for RFA AI 12 059 Funding Number: RFA AI 12 059 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Family Planning and Reproductive Health Methods APS Apply for SOL OAA 13 000024 Funding Number: SOL OAA 13 000024 Agency: Agency for International Development Category: Health Funding Amount: $80,000,000 |
| Statewide Consumer Network Grant Apply for SM 13 004 Funding Number: SM 13 004 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $70,000 |
| Implementing Public Health Programs and Strengthening Public Health Capacity in Guatemala and Central American Apply for CDC RFA GH13 1306 Funding Number: CDC RFA GH13 1306 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $4,000,000 |
| Engaging Parents in Prevention of Child Sexual Abuse and Sexual Risk Behaviors Targeting Youth Scaling up the Implementation of Families Matter in the United Republic of Tanzania under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 1324 Funding Number: CDC RFA GH13 1324 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,200,000 |
| Clinical Neuroscience and Entertainment Software Pilot Partnership Program to Develop Neuropsychiatric Interventions (R43/R44) Apply for RFA MH 14 010 Funding Number: RFA MH 14 010 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition Revisions for DNA Collection from Existing Longitudinal Aging Cohorts in Africa (R01) Apply for RFA AG 13 018 Funding Number: RFA AG 13 018 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIMHD Minority Health and Health Disparities International Research Training (T37) Apply for RFA MD 13 002 Funding Number: RFA MD 13 002 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Biodynamics Grant Opportunity Apply for 13 01 Funding Number: 13 01 Agency: DOT FAA Aviation Research Grants Category: Health Funding Amount: $750,000 |
| Small Rural Hospital Improvement Grant Program (SHIP) Apply for HRSA 13 163 Funding Number: HRSA 13 163 Agency: Health Resources and Services Administration Category: Health Funding Amount: $9,000 |
| New Access Point Grants Apply for HRSA 13 228 Funding Number: HRSA 13 228 Agency: Health Resources and Services Administration Category: Health Funding Amount: $650,000 |
| Saving Lives at Birth A Grand Challenge for Development (Round 3) Apply for RFA OAA 13 000004 Funding Number: RFA OAA 13 000004 Agency: Agency for International Development Category: Health Funding Amount: Case Dependent |
| Strengthen Brazils National Response to HIV and other diseases through innovative and evidence based approaches in laboratory, strategic information, prevention and care activities and foster partnerships between Brazil, Angola and Mozambique (PEPFAR Apply for CDC RFA GH13 1343 Funding Number: CDC RFA GH13 1343 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $3,500,000 |
| Tanzanian Ministry of Health and Social Welfare System Strengthening for Enhanced Evidence Based Decision Making and Management and Delivery of Quality Health Services in the United Republic of Tanzania under the Presidents Emergency Plan for AIDS Re Apply for CDC RFA GH13 1319 Funding Number: CDC RFA GH13 1319 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,000,000 |
| Rural Training Track Technical Assistance Demonstration Program Apply for HRSA 13 247 Funding Number: HRSA 13 247 Agency: Health Resources and Services Administration Category: Health Funding Amount: $300,000 |
| Modification 1 Questions and Answer to the APS Apply for APS 442 13 000001 Funding Number: APS 442 13 000001 Agency: Cambodia USAID Phnom Penh Category: Health Funding Amount: $100,000 |
| Drug Free Communities (DFC) Support Program Apply for SP 13 002 Funding Number: SP 13 002 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $125,000 |
| Support for Community Vital Registration in the Republic of Zambia under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 1349 Funding Number: CDC RFA GH13 1349 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,500,000 |
| HIV care and treatment services in the Dukwi refugee camp in Botswana under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 1355 Funding Number: CDC RFA GH13 1355 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH13 1327", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.